. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Clinical Trials as TopicDiabetes Mellitus, Type 2/drug therapyDrug CombinationsHumansHypoglycemic Agents/administration & dosageHypoglycemic Agents/adverse effectsHypoglycemic Agents/pharmacokineticsHypoglycemic Agents/therapeutic useMetformin/administration & dosageMetformin/adverse effectsMetformin/pharmacokineticsMetformin/therapeutic usePyrazines/administration & dosagePyrazines/adverse effectsPyrazines/pharmacokineticsPyrazines/therapeutic useSitagliptin PhosphateTreatment OutcomeTriazoles/administration & dosageTriazoles/adverse effectsTriazoles/pharmacokineticsTriazoles/therapeutic use
Substances: See more » Drug CombinationsHypoglycemic AgentsPyrazinesTriazolesMetforminSitagliptin Phosphate
Year: 2007 PMID: 17541377
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN: 0025-732X Impact factor: 1.909